Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 108929-04-0 Chemical Structure| 108929-04-0

Structure of Epinastine HCl
CAS No.: 108929-04-0

Chemical Structure| 108929-04-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Epinastine HCl is an antihistamine and mast cell stabilizer that is used in eye drops to treat allergic conjunctivitis.

Synonyms: WAL801 hydrochloride; Epinastine (hydrochloride); WAL 801CL

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Epinastine HCl

CAS No. :108929-04-0
Formula : C16H16ClN3
M.W : 285.77
SMILES Code : NC1=NCC2N1C3=CC=CC=C3CC4=CC=CC=C24.[H]Cl
Synonyms :
WAL801 hydrochloride; Epinastine (hydrochloride); WAL 801CL
MDL No. :MFCD00933434

Safety of Epinastine HCl

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P301+P310
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Epinastine HCl

GPCR

Isoform Comparison

Biological Activity

Target
  • Histamine receptor

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01569191 Hypersensitivity Phase 4 Completed - United Kingdom ... More >> National Pollen and Aerobiology Unit Worcester, United Kingdom, WR2 6AJ Less <<
NCT01569191 - Completed - -
NCT01363700 Allergic Conjunctivitis Phase 3 Completed - Japan ... More >> Santen study sites Osaka, Japan Less <<
NCT01363700 - Completed - -
NCT00534794 Allergic Conjunctivitis Phase 4 Completed - United States, Massachusetts ... More >> Ophthalmic Consultants of Boston Boston, Massachusetts, United States, 02114 Less <<
NCT00534794 - Completed - -
NCT00407927 Seasonal Allergic Rhinitis Phase 2 Completed - United States, Texas ... More >> Allergy & Asthma Associates Austin, Texas, United States, 78731 Lovelace Scientific Resources, Inc. Austin, Texas, United States, 78759 Kerrville Research Associates Kerrville, Texas, United States, 78028 Central Texas Health Research New Braunfels, Texas, United States, 78130 Biogenics Research Institute San Antonio, Texas, United States, 78229 Sylvana Research Associates San Antonio, Texas, United States, 78229 Allergy Asthma Research Institute Waco, Texas, United States, 76712 Less <<
NCT02251613 Allergic Conjunctivitis Phase 4 Completed - -
NCT02251613 - Completed - -
NCT00564421 Seasonal Allergic Rhinitis Phase 3 Completed - -
NCT02260037 Healthy Phase 1 Completed - -
NCT02182557 Dermatitis, Atopic Phase 3 Completed - -
NCT02182531 Healthy Phase 1 Completed - -
NCT02182544 Rhinitis, Allergic, Perennial Phase 3 Completed - -
NCT01382654 Allergic Rhinitis Phase 2 Completed - -
NCT02260050 Healthy Phase 1 Completed - -
NCT02238236 - Completed - -
NCT02238249 - Completed - -
NCT02260063 Healthy Phase 1 Completed - -
NCT02182518 Rhinitis, Allergic, Perennial Phase 3 Completed - -
NCT02238223 - Completed - -
NCT00489398 Allergic Conjunctivitis Phase 4 Withdrawn(Protocol changes) December 2008 -
NCT02182570 Dermatitis, Atopic Phase 3 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.50mL

0.70mL

0.35mL

17.50mL

3.50mL

1.75mL

34.99mL

7.00mL

3.50mL

References

 

Historical Records

Categories